ClinicalTrials.govcontrolled
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
ClinicalTrials.gov study NCT02864992. IPD Sharing: YES. Countries: 15. Publications: 7.
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8